Clinical Trial Update: Efficacy of Inhaled Cannabis for Acute Migraine Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating inhaled cannabis for acute migraine treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• CBD (cannabidiol)
• Cannabis (Cannabis)
• THC (tetrahydrocannabinol)

Snippet

Sponsor: University of California, San Diego | Conditions: Migraine, Cannabis | Phase 2 | Status: COMPLETED